Jefferies Group LLC Emergent Bio Solutions Inc. Transaction History

Jefferies Group LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$27.42 - $43.63 $418,867 - $666,491	15,276 New	15,276 $36,000
Q4 2019 Feb 13, 2020	SELL	$51.21 - $59.06 $583,998 - $673,520	-11,404 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$40.6 - $57.2 $463,002 - $652,308	11,404 New	11,404 $596,000
Q3 2018 Nov 14, 2018	SELL	$52.05 - $66.51 $370,387 - $473,285	-7,116 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$48.33 - $55.64 $100,961 - $116,231	2,089 Added 41.56%	7,116 $359,000
Q1 2018 May 15, 2018	BUY	$44.44 - $54.39 $223,399 - $273,418	5,027 New	5,027 $265,000
Q4 2017 Feb 14, 2018	SELL	$37.77 - $47.75 $198,028 - $250,353	-5,243 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$34.14 - $40.45 $178,996 - $212,079	5,243	5,243 $212,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $515M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.